Viewing Study NCT06353906


Ignite Creation Date: 2025-12-26 @ 10:59 AM
Ignite Modification Date: 2025-12-26 @ 10:59 AM
Study NCT ID: NCT06353906
Status: RECRUITING
Last Update Posted: 2025-12-08
First Post: 2024-03-15
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer
Sponsor: The Netherlands Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module